Alectinib is an anticancer drug prescribed for treating ALK-positive metastatic non-small-cell lung cancer (NSCLC), a type of lung cancer detected by an FDA approved test.
More Info about Alectinib
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer
© All Rights Reserved 1997 - 2022
This site complies with the HONcode standard for trustworthy health information: verify here.